or Try an Advanced Search...

    Serious Diseases Stocks List

    Symbol Grade Name % Change
    VCNX F Vaccinex, Inc. -2.10
    CYCCP F Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock -12.32
    BMY F Bristol-Myers Squibb Company 0.66
    MNOV F MediciNova, Inc. -5.07
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Biology Biopharmaceutical Cancer Clinical Development Melanoma Multiple Sclerosis Antibodies Antibody Asthma Atrial Fibrillation Autoimmune And Inflammatory Disease Autoimmune Disorders Biopharmaceutical Products Biotechnology Bronchial Asthma Cancer Cell Cancer Treatment Cdk Inhibitor Cell Biology Cell Cycle

    Related ETFs - A few ETFs which own one or more of the above listed Serious Diseases stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 6.67
    MEDX F Horizon Kinetics Medical ETF 5.43
    WBIY D WBI Power Factor High Dividend ETF 4.72
    XPH D SPDR S&P Pharmaceuticals ETF 4.05
    MVAL F SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 4.0
    View all Serious Diseases ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to MVAL Compare MEDX to WBIY

        Serious Diseases Stocks Recent News

        Date Stock Title
        May 4 BMY Pharma R&D productivity seen improving for the first time in years - Deloitte
        May 4 BMY Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
        May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
        May 3 BMY If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
        May 3 BMY The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
        May 3 BMY Bristol-Myers Squibb: A Lost Decade?
        May 2 BMY Schrodinger gets rights to cancer drug candidate back from Bristol
        May 2 BMY Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
        May 1 BMY Editas, Bristol Myers extend T cell therapy collaboration
        May 1 BMY Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
        Apr 30 BMY Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
        Apr 30 BMY J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations
        Apr 30 MNOV MediciNova (NASDAQ:MNOV) investors are sitting on a loss of 89% if they invested five years ago
        Apr 30 BMY Bristol Myers Squibb: Tough Times Continue
        Apr 29 BMY J&J, Bristol Myers lose challenges to US drug price negotiation program
        Apr 29 BMY Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact
        Apr 29 BMY Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
        Apr 29 BMY Repertoire pivot pays dividends with Bristol Myers deal
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Biology Biopharmaceutical Cancer Clinical Development Melanoma Multiple Sclerosis Antibodies Antibody Asthma Atrial Fibrillation Autoimmune And Inflammatory Disease Autoimmune Disorders Biopharmaceutical Products Biotechnology Bronchial Asthma Cancer Cell Cancer Treatment Cdk Inhibitor Cell Biology Cell Cycle
        Serious Diseases

        Serious diseases are illnesses that have a significant impact on a person's health and quality of life. These diseases can be life-threatening and require intensive medical care. Examples of serious diseases include cancer, heart disease, stroke, diabetes, HIV/AIDS, and Alzheimer's disease.

        Browse All Tags